Navigation Links
RainEarth (RNER) Complies with Chinese Medical Service Reforms to Provide Better and Cheaper Blood Dialysis
Date:9/2/2009

BEIJING, Sept. 2 /PRNewswire-Asia/ -- RainEarth Inc. (OTC Bulletin Board: RNER; "the Company") announced that in the second quarter of 2009, the Xinhua News Agency publicized the creation of "Opinions of the CPC Central Committee and the State Council on Deepening the Reform of the Medical and Health Care System" ("Opinion").

The "Opinion" proposed practical methods to enable people to go see a doctor more easily. Reduced cost is the short-term goal and the long-term goal is to establish a medical coverage plan for urban and rural populations that meets their basic medical requirements more effectively and conveniently.

The Company's Chinese subsidiary, Beijing Rain and Earth Technology Development Corp. Ltd. ("China RainEarth") not only complied with this system of medical reform, but will also continue improving the quality of its products while keeping prices competitive and affordable for patients.

China RainEarth's main product, blood dialysis, is an effective measure for patients with acute and chronic renal failure (uremia) to sustain their lives. Currently, there are about 60,000 renal failure patients, who spend more than RMB six billion (approximately US$882 Million) every year on blood dialysis in China.

Currently, imported products dominate the market. Comparatively, domestic products only have less than 2% market share. With social and economic development as well as the improvement of healthcare services, 15 million blood dialyzers will be sold in China by 2012 and the market size will hit RMB 1.2 billion (approximately US$176 million). At that time, the market share of domestic products will exceed 50%.

"Our blood dialysis is up to 40% cheaper than other imported dialysis. Of course our dialysis maintains the same high quality," said Yongfu Zhu, CEO of the Company. "Our dialysis has been used by several hospitals and as it is recognized by more patients and hospitals, we will see continued growth for the Company."

About the Company

RainEarth Inc. (formerly Gold Rock Resources Inc., the "Company") was incorporated in the State of Nevada on March 14, 2006. The Company is a developing-stage company that initially engaged in the search for mineral deposits or reserves.

On March 25, 2009, the Company and China RainEarth, a company organized and existing under the laws of the People's Republic of China, entered into a Business Cooperation Agreement (the "Agreement") for a term of twenty years. The purpose of the Agreement is to jointly conduct Hollow Fiber Membrane Materials' application and manufacturing in China (the "Business"). The main product that utilizes this technology is the blood dialyzer.

The Company will provide advice and assistance relating to the development of marketing and consultancy services, particularly as related to the Business. China RainEarth will give 60% of its revenue after deduction of direct operating costs, expenses and taxes to the Company in consideration of the Company's services.

Forward-looking statements

This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. Forward-looking statements involve risks and uncertainties including, but not limited to, economic and political factors; developments of the Chinese and North American markets and changes in regulatory matters; our business strategies and future plans of operations; the market acceptance and amount of sales of our products and services; our historical losses; the competitive environment within the industries in which we compete; and our ability to raise additional capital, currently needed for expansion. The Company cautions that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements due to several important factors.

    For more information, please contact:

     RainEarth Inc.
     Public Relations Department
     Tel:   +852-3005-7220
     Email: Investor@rainearth.net

'/>"/>
SOURCE RainEarth Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RainEarth (RNER) Signs Purchase Agreement with HangZhou Municipal No.3 Peoples Hospital
2. RainEarth Obtains Patent Approvals for Its Core Technology
3. RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment
4. Gold Rock Changed Name to RainEarth Inc. and Launches New English Web Site
5. AllMeds' EMR Receives CCHIT 2008 Certification Software Complies with 100 Percent of Certification Criteria
6. Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification Software Complies with Updated Interoperability Requirements
7. IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification
8. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
9. Proven Solution for Chinese Drywall is Now Available
10. Chinese women join global breast cancer trial
11. Chinese Drywall Litigation & Insurance Conference July 28 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... Dr. Robert Mondavi, one of the dentists in Torrance , is now ... as more patients are discovering the many different ways they can change and improve ... to them and which ones might work for their smiles. , “One of ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... Newport Beach, CA (PRWEB) , ... April 29, 2016 , ... ... Dr. Jane L. Frederick, Dr. Sanaz Ghazal, and Dr. Daniel A. Potter -- are ... the Society for Assisted Reproductive Technology (SART). In April, SART published the ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Tie-up with Government hospitals as ... to save newborns   Fortis La Femme, ... collaboration with Breast Milk Foundation (BMF), a non-profit organization within ... Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that ... and should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, ... of Jennifer Hagerman , Pharm D., to Vice ... growing role at Diplomat, Hagerman will continue to lead ... company that delivers custom education and training to Diplomat ... specialty pharmacy industry. Diplomat University also houses the quality ...
Breaking Medicine Technology: